Abstract
Human E1 is a key player in protein ubiquitination, however the E1 structure is not available. In this paper, we describe the derivation of a human E1 structure using molecular modelling based on the crystal structure of S. cerevisiae E1 and M. Musculus E1. Key interactions between our E1 model and ubiquitin are also discussed.
Keywords: Ubiquitination, Human E1, Ubiquitin activating enzyme, Homology modelling
Letters in Drug Design & Discovery
Title: Homology Modelling of Human E1 Ubiquitin Activating Enzyme
Volume: 7 Issue: 1
Author(s): Ghali Brahemi, Angelika M. Burger, Andrew D. Westwell and Andrea Brancale
Affiliation:
Keywords: Ubiquitination, Human E1, Ubiquitin activating enzyme, Homology modelling
Abstract: Human E1 is a key player in protein ubiquitination, however the E1 structure is not available. In this paper, we describe the derivation of a human E1 structure using molecular modelling based on the crystal structure of S. cerevisiae E1 and M. Musculus E1. Key interactions between our E1 model and ubiquitin are also discussed.
Export Options
About this article
Cite this article as:
Brahemi Ghali, Burger M. Angelika, Westwell D. Andrew and Brancale Andrea, Homology Modelling of Human E1 Ubiquitin Activating Enzyme, Letters in Drug Design & Discovery 2010; 7 (1) . https://dx.doi.org/10.2174/157018010789869316
DOI https://dx.doi.org/10.2174/157018010789869316 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacogenomics of Sex Difference in Chemotherapeutic Toxicity
Current Drug Discovery Technologies Meet Our Editorial Board Member
Mini-Reviews in Medicinal Chemistry Type 2 Diabetes and Obesity Metabolic Interactions: Common Factors for Breast Cancer Risk and Novel Approaches to Prevention and Therapy
Current Diabetes Reviews Titanium Dioxide Nanoparticles: a Risk for Human Health?
Mini-Reviews in Medicinal Chemistry Anaemia in Diabetes: An Emerging Complication of Microvascular Disease
Current Diabetes Reviews Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery Development of Meat and Poultry Products Enriched with n-3 PUFAs and their Functional Role
Current Nutrition & Food Science The Role of HTS in Drug Discovery at the University of Michigan
Combinatorial Chemistry & High Throughput Screening Voltage-Gated Ion Channels, New Targets in Anti-Cancer Research
Recent Patents on Anti-Cancer Drug Discovery Targeting Upstream Kinases of STAT3 in Human Medulloblastoma Cells
Current Cancer Drug Targets One-pot Synthesis of 2-Hydroxy-1,4-Naphthoquinone (Lawsone)
Current Organic Synthesis Clinical Pharmacology of Novel Selective COX-2 Inhibitors
Current Pharmaceutical Design Meet Our Associate Editor
Current Drug Metabolism Mediterranean Diet And Longevity: An Example Of Nutraceuticals?
Current Vascular Pharmacology Stable Indomethacin Dispersions in Water from Drug, Ethanol, Cationic Lipid and Carboxymethyl-Cellulose
Pharmaceutical Nanotechnology Antiviral Activity of Substituted Salicylanilides - A Review
Mini-Reviews in Medicinal Chemistry Therapeutic Strategy of Advanced Hepatocellular Carcinoma by Using Combined Intra-Arterial Chemotherapy
Recent Patents on Anti-Cancer Drug Discovery Research Advances in Neuroblastoma Immunotherapy
Current Pediatric Reviews Apoptosis is a Critical Cellular Event in Cancer Chemoprevention and Chemotherapy by Selenium Compounds
Current Cancer Drug Targets Cytochrome P450s: Mechanisms and Biological Implications in Drug Metabolism and its Interaction with Oxidative Stress
Current Drug Metabolism